Abstract

BackgroundAngiotensin I-converting enzyme (ACE) plays an important role in cardiovascular homeostasis. There is evidence from different ethnic groups that circulating ACE levels are influenced by a quantitative trait locus (QTL) at the ACE gene on chromosome 17. The finding of significant residual familial correlations in different ethnic groups, after accounting for this QTL, and the finding of support for linkage to a locus on chromosome 4 in Mexican-American families strongly suggest that there may well be QTLs for ACE unlinked to the ACE gene.MethodsA genome-wide panel of microsatellite markers, and a panel of biallelic polymorphisms in the ACE gene were typed in Nigerian families. Single locus models with fixed parameters were used to test for linkage to circulating ACE with and without adjustment for the effects of the ACE gene polymorphisms.ResultsStrong evidence was found for D17S2193 (Zmax = 3.5); other nearby markers on chromosome 17 also showed modest support. After adjustment for the effects of the ACE gene locus, evidence of "suggestive linkage" to circulating ACE was found for D4S1629 (Zmax = 2.2); this marker is very close to a locus previously shown to be linked to circulating ACE levels in Mexican-American families.ConclusionIn this report we have provided further support for the notion that there are QTLs for ACE unlinked to the ACE gene; our findings for chromosome 4, which appear to replicate the findings of a previous independent study, should be considered strong grounds for a more detailed examination of this region in the search for genes/variants which influence ACE levels.The poor yields, thus far, in defining the genetic determinants of hypertension risk suggest a need to look beyond simple relationships between genotypes and the ultimate phenotype. In addition to incorporating information on important environmental exposures, a better understanding of the factors which influence the building blocks of the blood pressure homeostatic network is also required. Detailed studies of the genetic determinants of ACE, an important component of the renin-angiotensin system, have the potential to contribute to this strategic objective.

Highlights

  • Angiotensin I-converting enzyme (ACE) plays an important role in cardiovascular homeostasis

  • The analysis of QT1 was conducted on families with ACE levels that were typed for the Marshfield markers

  • The analysis of QT2 was conducted on a subset of these families that were typed for ACE gene markers

Read more

Summary

Introduction

Angiotensin I-converting enzyme (ACE) plays an important role in cardiovascular homeostasis. Angiotensin I-converting enzyme (ACE) plays an important role in the maintenance of cardiovascular homeostasis [1,2,3]. Clinical trials have shown that the use of ACE inhibitor medication in cardiovascular and renal disease, and among persons at high risk for heart disease confers benefits that may be independent of blood pressure lowering [8,9,10,11,12,13,14]. The apparent difficulty that has been experienced far in identifying susceptibility genes for essential hypertension [16], and the possibility that genetically-determined variation in ACE activity might influence either risk of disease, or of outcomes among patients treated with ACE inhibitor or other medications, continues to fuel interest in defining the mechanisms that influence ACE activity

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call